Mark S. Walker
Impact in
- Oncology top 5%
- Cancer survivorship and care
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
Papers in
- Oncology 54
- Cancer Treatment and Pharmacology 16
- Cancer survivorship and care 9
-
- Lung Cancer Treatments and Mutations 16
- Advanced Breast Cancer Therapies 10
- Renal cell carcinoma treatment 9
- Lung Cancer Diagnosis and Treatment 8
- Co-authors
- Lee S. Schwartzberg (38 shared papers)Edwin B. Fisher (7 shared papers)Edward J. Stepanski (27 shared papers)Paul J. Miller (20 shared papers)Randy J. Larsen (3 shared papers)Stephen L. Ristvedt (1 shared paper)Bruce H. Haughey (1 shared paper)Ramaswamy Govindan (2 shared papers)
- Journals
- Journal of Clinical Oncology (27 papers)Future Oncology (4 papers)Clinical Lung Cancer (4 papers)Psycho-Oncology (4 papers)Journal of Medical Economics (3 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Mark S. Walker
118 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 120
- Oncology 565
- Clinical Biochemistry 102
- Pulmonary and Respiratory Medicine 410
- Cancer Research 131
- Physiology 201
Countries citing papers authored by Mark S. Walker
This map shows the geographic impact of Mark S. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Walker more than expected).
Fields of papers citing papers by Mark S. Walker
This network shows the impact of papers produced by Mark S. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Walker. The network helps show where Mark S. Walker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 114 | |
| 2 | 2009 | 113 | |
| 3 | 2005 | 101 | |
| 4 | 2008 | 89 | |
| 5 | 2003 | 83 | |
| 6 | 2005 | 83 | |
| 7 | 1999 | 82 | |
| 8 | 2017 | 68 | |
| 9 | 2015 | 67 | |
| 10 | 2004 | 60 | |
| 11 | 2013 | 45 | |
| 12 | 2014 | 42 | |
| 13 | 2012 | 42 | |
| 14 | 1998 | 41 | |
| 15 | 2010 | 40 | |
| 16 | 2020 | 38 | |
| 17 | 2006 | 36 | |
| 18 | 2014 | 36 | |
| 19 | 2017 | 36 | |
| 20 | 2016 | 32 |
About Mark S. Walker
Mark S. Walker is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 125 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), Lung Cancer Treatments and Mutations (16 papers), Advanced Breast Cancer Therapies (10 papers), Renal cell carcinoma treatment (9 papers), Breast Cancer Treatment Studies (9 papers), Cancer survivorship and care (9 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (565 citations), Clinical Biochemistry (102 citations), Pulmonary and Respiratory Medicine (410 citations), Cancer Research (131 citations) and Physiology (201 citations). Mark S. Walker has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Lee S. Schwartzberg, Edwin B. Fisher, Edward J. Stepanski, Paul J. Miller, Randy J. Larsen, Stephen L. Ristvedt, Bruce H. Haughey, Ramaswamy Govindan, L. Johnetta Blakely and Patrick F. Chinnery. Their work appears in journals such as Journal of Clinical Oncology, Future Oncology, Clinical Lung Cancer, Psycho-Oncology and Journal of Medical Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.